Stocks Overview

LAST PRICE
33.3100
TODAY'S CHANGE (%)
Trending Down-1.1700 (-3.3933%)

Bid / Lots
31.0000/ 97
Ask / Lots
32.4400/ 1
Open / Previous Close
34.1500 / 34.4800
Day Range
Low 33.1100
High 34.3000
52 Week Range
Low 20.8400
High 35.2200
Volume
778,469
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Thursday's close: 34.48
Time	Volume	CORT
09:32 ET	10811	33.7704
09:34 ET	860	34.03
09:39 ET	100	33.725
09:41 ET	1058	33.9
09:43 ET	2749	34.2595
09:45 ET	200	34.09
09:48 ET	327	34.07
09:50 ET	300	34.205
09:52 ET	1482	34.03
09:54 ET	540	34.04
09:56 ET	4959	34.04
09:57 ET	600	34.0234
09:59 ET	200	34.02
10:01 ET	3029	33.895
10:03 ET	8794	33.84
10:06 ET	1975	33.9
10:08 ET	917	33.765
10:10 ET	1281	33.88
10:12 ET	900	33.9
10:14 ET	2269	33.59
10:15 ET	696	33.54
10:17 ET	1666	33.55
10:19 ET	604	33.46
10:21 ET	1158	33.54
10:24 ET	1461	33.53
10:26 ET	567	33.57
10:28 ET	1796	33.65
10:30 ET	1137	33.7
10:32 ET	300	33.66
10:35 ET	450	33.63
10:37 ET	607	33.64
10:39 ET	906	33.64
10:42 ET	3424	33.68
10:44 ET	600	33.61
10:48 ET	900	33.715
10:50 ET	400	33.76
10:51 ET	827	33.7
10:53 ET	1008	33.64
10:55 ET	1800	33.525
10:57 ET	7046	33.445
11:00 ET	595	33.385
11:02 ET	3982	33.38
11:04 ET	663	33.38
11:06 ET	830	33.4
11:08 ET	1331	33.37
11:09 ET	400	33.39
11:11 ET	7848	33.21
11:13 ET	800	33.21
11:15 ET	4579	33.24
11:18 ET	1000	33.24
11:20 ET	963	33.21
11:22 ET	6178	33.22
11:24 ET	1144	33.31
11:26 ET	776	33.52
11:31 ET	400	33.49
11:33 ET	922	33.55
11:36 ET	1000	33.605
11:38 ET	800	33.6
11:40 ET	503	33.6
11:42 ET	300	33.59
11:44 ET	350	33.65
11:45 ET	1050	33.65
11:47 ET	425	33.62
11:51 ET	756	33.61
11:54 ET	100	33.555
11:56 ET	1700	33.485
11:58 ET	537	33.4508
12:00 ET	19019	33.4
12:02 ET	238	33.35
12:03 ET	100	33.305
12:05 ET	1453	33.3
12:07 ET	400	33.33
12:09 ET	857	33.32
12:14 ET	1713	33.315
12:16 ET	3000	33.38
12:18 ET	141	33.39
12:20 ET	5150	33.4001
12:21 ET	300	33.4
12:23 ET	100	33.38
12:27 ET	1598	33.325
12:30 ET	1281	33.22
12:32 ET	20235	33.37
12:34 ET	850	33.445
12:36 ET	100	33.62
12:38 ET	875	33.475
12:39 ET	100	33.4
12:41 ET	300	33.38
12:43 ET	1583	33.42
12:45 ET	400	33.39
12:48 ET	1482	33.36
12:50 ET	1349	33.27
12:52 ET	631	33.21
12:54 ET	1767	33.26
12:56 ET	1440	33.3
12:57 ET	1484	33.355
12:59 ET	600	33.41
01:03 ET	903	33.43
01:06 ET	500	33.4
01:10 ET	536	33.41
01:12 ET	400	33.33
01:14 ET	200	33.32
01:15 ET	2050	33.29
01:17 ET	1400	33.33
01:19 ET	400	33.33
01:24 ET	2400	33.46
01:26 ET	100	33.47
01:28 ET	552	33.445
01:32 ET	546	33.42
01:33 ET	429	33.46
01:35 ET	100	33.41
01:37 ET	100	33.4
01:39 ET	600	33.41
01:42 ET	3482	33.3
01:44 ET	1907	33.295
01:46 ET	1700	33.32
01:48 ET	1792	33.41
01:51 ET	13013	33.4
01:53 ET	1275	33.4
01:55 ET	383	33.31
01:57 ET	1100	33.31
02:00 ET	814	33.33
02:02 ET	417	33.29
02:04 ET	100	33.22
02:06 ET	1754	33.26
02:08 ET	850	33.25
02:09 ET	307	33.19
02:11 ET	500	33.2
02:13 ET	1318	33.2
02:15 ET	1218	33.23
02:18 ET	100	33.2
02:20 ET	1134	33.225
02:22 ET	2015	33.305
02:24 ET	732	33.26
02:26 ET	200	33.29
02:27 ET	400	33.3
02:29 ET	1322	33.3
02:31 ET	1839	33.435
02:33 ET	400	33.46
02:36 ET	1149	33.51
02:38 ET	1450	33.5
02:40 ET	500	33.515
02:42 ET	1478	33.51
02:44 ET	1872	33.595
02:45 ET	700	33.61
02:47 ET	722	33.63
02:49 ET	700	33.635
02:51 ET	1508	33.63
02:54 ET	4146	33.52
02:56 ET	350	33.53
02:58 ET	2254	33.54
03:00 ET	2479	33.52
03:02 ET	1326	33.48
03:03 ET	1100	33.59
03:05 ET	1525	33.6
03:07 ET	750	33.6
03:09 ET	1030	33.61
03:12 ET	1082	33.6025
03:14 ET	2598	33.675
03:16 ET	850	33.69
03:18 ET	1202	33.725
03:20 ET	4500	33.69
03:21 ET	4677	33.64
03:23 ET	3820	33.655
03:25 ET	1130	33.71
03:27 ET	1454	33.68
03:30 ET	3851	33.525
03:32 ET	2310	33.525
03:34 ET	2268	33.6325
03:36 ET	1127	33.59
03:38 ET	4666	33.66
03:39 ET	2533	33.67
03:41 ET	1642	33.621
03:43 ET	2852	33.6
03:45 ET	2417	33.505
03:48 ET	4186	33.47
03:50 ET	6025	33.515
03:52 ET	14694	33.455
03:54 ET	8789	33.45
03:56 ET	11746	33.307
03:57 ET	24675	33.37
03:59 ET	149650	33.31

Data delayed at least 15 minutes.

Jun 4, 2024
- DJ Corcept Therapeutics Price Target Raised to $65.00/Share From $44.00 by Truist Securities, from 9:32AM ET on Tuesday Jun 04, 2024 by Dow Jones
  9:32AM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
- Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing's Syndrome), from 8:00AM ET on Monday Jun 03, 2024 by Dow Jones
  8:00AM ET on Monday Jun 03, 2024 by Dow Jones
May 29, 2024
- DJ Corcept Therapeutics Price Target Maintained With a $40.00/Share by HC Wainwright & Co., from 7:06AM ET on Wednesday May 29, 2024 by Dow Jones
  7:06AM ET on Wednesday May 29, 2024 by Dow Jones
May 28, 2024
- DJ Corcept Therapeutics Shares Rise 9% After Relacorilant Trial Meets Primary Endpoint, from 9:38AM ET on Tuesday May 28, 2024 by Dow Jones
  9:38AM ET on Tuesday May 28, 2024 by Dow Jones
- Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing's Syndrome), from 8:00AM ET on Tuesday May 28, 2024 by Dow Jones
  8:00AM ET on Tuesday May 28, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesCORT Corcept Therapeutics Inc	3.4B	31.2x	+9.80%
United StatesHCM HUTCHMED (China) Ltd	3.3B	30.9x	---
United StatesANIP ANI Pharmaceuticals Inc	1.4B	41.9x	-8.16%
United StatesAMPH Amphastar Pharmaceuticals Inc	2.1B	14.0x	---
United StatesHRMY Harmony Biosciences Holdings Inc	1.7B	13.2x	---
United StatesIMCR Immunocore Holdings PLC	2.2B	-34.7x	---
As of 2024-06-09

Corcept Therapeutics Incorporated is a commercial-stage company, which is engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, exicorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.

Contact Information

Headquarters: 149 Commonwealth DrMENLO PARK, CA, United States 94025
Phone: 650-688-8803
Fax: 650-327-3218

Executives

Independent Chairman of the Board: James Wilson
President, Chief Executive Officer, Co-Founder, Director: Joseph Belanoff
Chief Financial Officer, Treasurer: Atabak Mokari
President - Corcept Endocrinology: Sean Maduck
President - Oncology: Roberto Vieira

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$3.6B
Revenue (TTM)	$523.5M
Shares Outstanding	104.1M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.43
EPS	$1.07
Book Value	$4.90
P/E Ratio	31.2x
Price/Sales (TTM)	6.8
Price/Cash Flow (TTM)	30.1x
Operating Margin	23.29%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Corcept Therapeutics Inc
NASDAQ:CORTUnited States

Search Criteria

Charts

Recent News

Jun 4, 2024

DJ Corcept Therapeutics Price Target Raised to $65.00/Share From $44.00 by Truist Securities, from 9:32AM ET on Tuesday Jun 04, 2024 by Dow Jones

Jun 3, 2024

Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing's Syndrome), from 8:00AM ET on Monday Jun 03, 2024 by Dow Jones

May 29, 2024

DJ Corcept Therapeutics Price Target Maintained With a $40.00/Share by HC Wainwright & Co., from 7:06AM ET on Wednesday May 29, 2024 by Dow Jones

May 28, 2024

DJ Corcept Therapeutics Shares Rise 9% After Relacorilant Trial Meets Primary Endpoint, from 9:38AM ET on Tuesday May 28, 2024 by Dow Jones

Corcept Announces Primary Endpoint Met in Pivotal Phase 3 GRACE Trial of Relacorilant in Patients With Hypercortisolism (Cushing's Syndrome), from 8:00AM ET on Tuesday May 28, 2024 by Dow Jones

Pharmaceuticals - Diversified Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar